Volume 15 Issue 05, May 2025
Impact factor: 2019: 4.679 2020: 5.015 2021: 5.436, 2022: 5.242, 2023:
6.995, 2024 7.75
http://www.internationaljournal.co.in/index.php/jasass
370
UNDERSTANDING RABIES: CHALLENGES AND ADVANCES IN CONTROL AND
PREVENTION
Jurayev Abdurakhim Turdalievich
Bostan Technical School of Public Health named after Abu Ali Ibn Sino
Abstract:
Rabies is a fatal zoonotic viral disease that affects the central nervous system
of mammals, including humans. Despite being preventable through vaccination, rabies continues
to cause significant morbidity and mortality, especially in developing countries. This article
reviews the pathogenesis of rabies virus infection, the epidemiology and modes of transmission,
current preventive measures including post-exposure prophylaxis (PEP), and the challenges
faced in global rabies control. Emphasis is placed on the need for integrated One Health
approaches to eliminate human rabies worldwide.
Keywords:
Rabies, zoonosis, rabies virus, post-exposure prophylaxis, vaccination, One
Health, epidemiology.
Rabies is a viral disease caused by neurotropic viruses of the genus
Lyssavirus
. It
primarily affects mammals and is transmitted to humans mainly through the bite of infected
animals, particularly dogs. The disease is characterized by acute encephalitis and is almost
invariably fatal once clinical symptoms appear. Globally, an estimated 59,000 people die from
rabies annually, with over 95% of these deaths occurring in Asia and Africa (WHO, 2022).
Despite the availability of effective vaccines and prophylactic treatments, rabies remains a
neglected public health issue, especially in resource-poor regions.
Pathogenesis of Rabies.
After an infected animal bite, the rabies virus enters peripheral
nerves and migrates centripetally towards the central nervous system (CNS). The incubation
period varies from weeks to months, depending on factors such as the bite location and viral load.
Once the virus reaches the brain, it causes encephalitis characterized by inflammation and
neuronal dysfunction. Clinical manifestations include hydrophobia, agitation, paralysis, and
ultimately coma and death. Death usually occurs within 7–10 days after symptom onset.
Additionally, the rabies virus has a unique ability to evade the host’s immune system
during its incubation period. Unlike many viral infections, rabies virus replication in muscle cells
near the site of inoculation occurs without triggering a strong local immune response. This
immune evasion facilitates the virus's silent progression toward the nervous system, making
early diagnosis challenging. Moreover, the virus travels along peripheral nerves rather than
through the bloodstream, which limits exposure to circulating antibodies and further complicates
immune detection. This neurotropic behavior underpins the urgency of immediate post-exposure
prophylaxis before neurological symptoms develop.
Epidemiology and Transmission.
Dogs are the primary reservoir and source of human
rabies cases globally. Other animals such as bats, raccoons, foxes, and skunks also act as
reservoirs, especially in the Americas and Europe. Rabies virus transmission mainly occurs via
saliva through bites or scratches. Human-to-human transmission is exceedingly rare but has been
documented in cases of organ transplantation.
Geographical and socio-economic factors greatly influence the epidemiology of rabies. In
low-income countries, especially in rural and peri-urban areas, lack of access to veterinary
services results in insufficient dog vaccination coverage, which maintains the enzootic cycle of
Volume 15 Issue 05, May 2025
Impact factor: 2019: 4.679 2020: 5.015 2021: 5.436, 2022: 5.242, 2023:
6.995, 2024 7.75
http://www.internationaljournal.co.in/index.php/jasass
371
rabies transmission. Additionally, cultural practices, such as reliance on traditional healers or
delayed seeking of medical care, increase the risk of fatal outcomes. In contrast, developed
countries have largely eliminated dog-mediated rabies through strict animal control laws,
widespread vaccination campaigns, and robust healthcare infrastructure, which underscores the
importance of sustained public health investment and education in rabies-endemic regions.
Prevention and Control.
The cornerstone of rabies prevention is vaccination, which has
proven highly effective in reducing the incidence of both human and animal rabies worldwide.
There are two key vaccination strategies:
Pre-exposure prophylaxis (PrEP):
This is recommended for individuals at high risk of
exposure to rabies virus, such as veterinarians, animal handlers, laboratory personnel, travelers to
endemic regions, and certain healthcare workers. PrEP involves a series of rabies vaccinations
before any exposure occurs, providing immunological priming that simplifies post-exposure
treatment if needed.
Post-exposure prophylaxis (PEP):
PEP is critical and involves immediate and thorough
wound cleansing, administration of rabies immunoglobulin (RIG) to neutralize virus at the
wound site, followed by a series of rabies vaccinations to stimulate active immunity. Timely
initiation of PEP can effectively prevent the onset of clinical rabies, which is otherwise almost
invariably fatal.
Mass dog vaccination campaigns represent the most cost-effective and sustainable
measure for preventing human rabies. Since domestic dogs are the main source of human
infections worldwide, vaccinating at least 70% of the dog population is necessary to interrupt
transmission cycles. Many countries have adopted community-based vaccination drives
combined with stray dog population management to achieve this goal.
Public education plays a vital role in rabies control by raising awareness about the
importance of avoiding dog bites, prompt wound cleaning, and seeking medical care
immediately after potential exposures. Programs targeting schoolchildren and rural communities
have been particularly effective in improving knowledge and practices related to rabies
prevention.
Despite these advances, access to PEP remains limited in many low- and middle-income
countries due to cost, vaccine shortages, and inadequate healthcare infrastructure. Efforts are
underway to develop new vaccine formulations that are more thermostable, require fewer doses,
and can be administered intradermally to reduce costs. Additionally, research into oral rabies
vaccines for wildlife and stray animals has shown promise in controlling rabies reservoirs that
complicate eradication efforts.
Coordination between veterinary and public health sectors under the
One Health
approach is increasingly recognized as essential for comprehensive rabies control. This
integrated strategy facilitates data sharing, resource allocation, and joint implementation of
vaccination and surveillance programs, ultimately aiming to eliminate human deaths from dog-
mediated rabies by 2030, in line with the World Health Organization’s global strategic plan.
Conclusion.
Rabies remains a critical yet preventable cause of death worldwide.
Strengthening vaccination coverage, improving healthcare access, and fostering international
collaboration are essential steps toward the WHO goal of zero human deaths from dog-mediated
rabies by 2030. A holistic approach combining scientific, medical, and social interventions is key
to overcoming the persistent burden of this ancient disease.
Volume 15 Issue 05, May 2025
Impact factor: 2019: 4.679 2020: 5.015 2021: 5.436, 2022: 5.242, 2023:
6.995, 2024 7.75
http://www.internationaljournal.co.in/index.php/jasass
372
Furthermore, sustained political commitment and community engagement are
indispensable for the success of rabies elimination programs. Empowering local communities
through education and involvement in vaccination campaigns enhances the effectiveness and
sustainability of control measures. Investments in research to develop innovative vaccines,
diagnostic tools, and treatment protocols will also play a vital role in addressing current gaps.
Ultimately, the eradication of rabies will not only save thousands of lives but also improve
overall public health infrastructure and foster a model for combating other zoonotic diseases.
References
1.
World Health Organization (2022).
Rabies Fact Sheet
. Retrieved from
https://www.who.int/news-room/fact-sheets/detail/rabies
2.
Fooks, A. R., Banyard, A. C., Horton, D. L., Johnson, N., McElhinney, L. M., & Jackson,
A. C. (2014). Current status of rabies and prospects for elimination.
The Lancet
, 384(9951),
1389-1399.
3.
Hampson, K., et al. (2015). Estimating the global burden of endemic canine rabies.
PLoS
Neglected Tropical Diseases
, 9(4), e0003709.
4.
Hemachudha, T., et al. (2013). Human rabies: neuropathogenesis, diagnosis, and
management.
The Lancet Neurology
, 12(5), 498-513.
